Pacira Pharmaceuticals stock forecast
Pacira Pharmaceuticals (82P) Stock Forecast & Price Target
82P Analyst Ratings
82P Stock 12 Month Forecast
Average Price Target
CHF30.60▲(0.00% Upside)Detailed List of Analyst Forecasts
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Hardik Parikh | J.P. Morgan | CHF19.33→CHF30.67 | hold | ― | Upgraded | 10/12/26 | ||
| Anish Nikhanj | Truist Financial | CHF26.05→CHF30.67 | hold | ― | Downgraded | 10/09/26 | ||
| Douglas Tsao | H.C. Wainwright | CHF31.93→CHF30.67 | hold | ― | Downgraded | 10/09/26 | ||
| Daniel Clark | Leerink Partners | CHF23.53→CHF30.67 | hold | ― | Reiterated | 10/09/26 | ||
| Serge Belanger | Needham | ― | hold | ― | Downgraded | 10/08/26 | ||
| Dennis Ding | Jefferies | CHF30.25 | hold | ― | Downgraded | 10/08/26 | ||
| Douglas Miehm | RBC Capital | CHF21.01→CHF30.67 | hold | ― | Assigned | 10/08/26 | ||
| Jenna Davidner | Barclays | CHF21.01 | hold | ― | Reiterated | 08/17/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Hardik ParikhJ.P. Morgan | HoldUpgradedCHF19.33→CHF30.67 | 10/12/26 | ― | ||
| Anish NikhanjTruist Financial | HoldDowngradedCHF26.05→CHF30.67 | 10/09/26 | ― | ||
| Douglas TsaoH.C. Wainwright | HoldDowngradedCHF31.93→CHF30.67 | 10/09/26 | ― | ||
| Daniel ClarkLeerink Partners | HoldReiteratedCHF23.53→CHF30.67 | 10/09/26 | ― | ||
| Serge BelangerNeedham | HoldDowngraded | 10/08/26 | ― | ||
| Dennis DingJefferies | HoldDowngradedCHF30.25 | 10/08/26 | ― | ||
| Douglas MiehmRBC Capital | HoldAssignedCHF21.01→CHF30.67 | 10/08/26 | ― | ||
| Jenna DavidnerBarclays | HoldReiteratedCHF21.01 | 08/17/26 | ― |
Best Analysts Covering Pacira Pharmaceuticals
Copying xAi Drug Manufacturers - Specialty and Generic's trades and holding each position for 3 Months would result in 33.33% of your transactions generating a profit, with an average return of -2.13% per trade.
Copying Google Drug Manufacturers - Specialty and Generic's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +19.90% per trade.
Copying Google Drug Manufacturers - Specialty and Generic's trades and holding each position for 2 Years would result in 50.00% of your transactions generating a profit, with an average return of +19.90% per trade.
82P Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 1 | 0 |
| Buy | 4 | 5 | 6 | 6 | 3 |
| Hold | 1 | 2 | 3 | 12 | 11 |
| Sell | 0 | 1 | 1 | 1 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 7 | 10 | 12 | 20 | 14 |
In the current month, 82P has received 3 Buy Ratings, 11 Hold Ratings, and 0 Sell Ratings. 82P average Analyst price target in the past 3 months is 30.60.
82P Financial Forecast
82P Earnings Forecast
Next quarter’s earnings estimate for 82P is CHF 0.59 with a range of ― to ―. The previous quarter’s EPS was CHF 0.59. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
82P Sales Forecast
Next quarter’s sales forecast for 82P is CHF 148.45M with a range of ― to ―. The previous quarter’s sales results were CHF 148.45M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

